Merck wins first FDA approval for Keytruda as a treatment for mesothelioma
Sep 18, 2024
Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for malignant plural mesothelioma, a rare cancer associated with asbestos.
https://www.marketwatch.com/story/mercks-wins-fda-approval-for-keytruda-in-combination-with-chemotherapy-as-a-treatment-for-rare-lung-disease-mpm-0dae5072?mod=mw_rss_topstories
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service